METHOD FOR EARLY DIAGNOSIS OF DISCIRCULATORY ENCEPHALOPATHY OF PATIENTS WITH HYPERTENSION AND INITIAL MANIFESTATION OF CIRCULATORY INSUFFICIENCY OF BRAIN

摘要

the invention u043eu0442u043du043eu0441u0438u0442u0441u00a0 to medicine, namely, to u043du0435u0432u0440u043eu043fu0430u0442u043eu043bu043eu0433u0438u0438, and can be used u0434u043bu00a0 u043fu043eu043eu0433u043du043eu0437u0438u0440u043eu0432u0430u043du0438u00a0 u0440u0430u0437u0432u0438u0442u0438u00a0 u0434u0438u0441u0446u0438u0440u043au0443u043bu00a0u0442u043eu0440u043du043eu0439 encephalopathy (c) ill the hypertensive disease (ia) with the primary u043fu0440u043eu00a0u0432u043bu0435u043du0438u00a0u043cu0438 failure u043au0440u043eu0432u043eu0441u043du0430u0431u0436u0435u043du0438u00a0 brain (u043du043fu043du043au043c). to improve the accuracy of the method u0438u0437u043eu0431u0440u0435u0442u0435u043du0438u00a0 u00a0u0432u043bu00a0u0435u0442u0441u00a0 by u043eu0431u0435u0441u043fu0435u0447u0435u043du0438u00a0 opportunities forecast of dae.the u0434u043eu0441u0442u0438u0433u0430u0435u0442u0441u00a0 u043fu043eu0441u0442u0430u0432u043bu0435u043du043du0430u00a0, u043fu0440u043eu0432u043eu0434u00a0u0442 clinical examination of the patient, with u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 paul and risk factors and their forward-looking u043au043eu044du0444u0444 u0438u0446u0438u0435u043du0442u044b fi and f2 on formulas: u0434u043bu00a0 males, 99 + 7,43 ai + 3.63 - u044d2 + 1.17 az + 97 + 34 + 3.25 as 2.33 ab + ab + ec + 2,23 4,81 3,48 ag + 1.36 - aio + 1,01 an + 4.25 aia: f2 - 5.27 + 5.7 ai + 1.45 32 + 42 + 0.02 - 34 35 36 + + + 4.09 2.33 4,13 37 + ab + 1.9 3,79 39 + 1.06 ayu + 0.72 atz + 2,51 aia; u0434u043bu00a0 women fi - 9,78 + 7.28 ai + 4.46 32 + 0.94 az + 3,98 34 + 5.15 35 + 3.73 36 + 4 86 - 37 - 1.78 ab + 3.36 - ae + 2.48 ayu + 097311 - 4.56 aia; 97 + 4.76 ai + 2.27 32 + 0.12 az + 1,96 34 + 3.82 as + 2.27 ae + 3.72 6 ab + 1.85 39 + 1.76 ayu + 0.49 atz -1.96 ai2 where figures u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u044eu0442 a constants u0434u0438u0441u043au0440u0438u043cu0438u043du0430u043du0442u043du043eu0433u043e u0443u0440u0430u0432u043du0435u043du0438u00a0 and the discriminant u043au043eu044du0444 u0444u0438u0446u0438u0435u043du0442u044b ai, 2.12 degrees of risk factors (ai - age, 32 u0438u0437u0431u044bu0442u043eu0447u043du0430u00a0 body mass; al psycho emotional u043du0430u043fu0440u00a0u0436u0435u043du0438u0435; 34 u0433u0438u043fu043eu043au0438u043du0435u0437u0438u00a0; as the smoking, ab - alcohol abuse; and - u043eu0442u00a0u0433u043eu0449u0435u043du043du0430u00a0 heredity; as a u043cu043eu0437u0433u043eu0432u0430u00a0 trauma history; chronic u0437u0430u0431u043eu043bu0435u0432u0430u043du0438u00a0 ent organsayu's prescription of arterial hypertension; it is the presence of hypertension related kriesow; ai2 - u0441u0442u0430u0434u0438u00a0 hypertensive disease). and the importance of predicting the development of dae with gb and u043du043fu043du043au043c. the proposed method u043fu043eu0437u0432u043eu043bu00a0u0435u0442 forecast with gb with u043du043fu043du043au043c the dae to u0440u0430u0437u0432u0438u0442u0438u00a0 its clinical u043fu0440u043eu00a0u0432u043bu0435u043du0438u0439 (accuracy u043fu0440u043eu0433u043du043eu0437u0438u0440u043eu0432u0430u043du0438u00a0 88.5%), it enables the threatened by dae to its active prevention. table 1 that with vi (vi x |.